
GSK vs PCRX
$GSK vs $PCRX head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
GSK vs PCRX: the quick read
- ·GSK is the larger company by market cap ($94.14B vs $1.45B).
- ·PCRX has been more active on our scanner (72 vs 63 alerts in 30 days).
- ·PCRX has the smaller float (34.1M vs 2.00B), which tends to mean sharper, more volatile moves.
- ·Both are pharmaceutical preparations names, so this is a like-for-like comparison and sector news tends to move them together.
- ·Both stay busy on our scanner, 72 and 63 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are not really peers by size: GSK is more than 65x the market cap of PCRX, so the same dollar of news moves PCRX far harder.
- ·They have diverged badly over the year: PCRX is near the top of its 52-week range while GSK is near the bottom of its own.
- ·GSK pays a dividend and PCRX does not, which usually means one is being held for income and the other for the move.
- ·PCRX is the one in play today, trading about 55x its normal volume, which is what puts a name on our scanner in the first place.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing GSK and PCRX on TheDesperateTrader.
- Is GSK or PCRX the better stock?
- "Better" depends on your goal, and these two are not alike. GSK is the larger company by market cap ($94.14B vs $1.45B). PCRX has been more active on our scanner (72 vs 63 alerts in 30 days). PCRX has the smaller float (34.1M vs 2.00B), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between GSK and PCRX?
- The differences that matter: GSK is roughly 65x the size of the other by market cap ($94.14B vs $1.45B); they trade at very different share prices ($46.83 vs $36.37); GSK sits at 21% of its 52-week range against 99% for PCRX; only GSK pays a dividend; our scanner flagged GSK 63 times in the last 30 days against 72 for PCRX. Everything above is measured from the latest completed session and SEC filings.
- Which of GSK and PCRX is more active right now?
- Right now GSK is at about 2.2x its normal volume and PCRX is at about 55.3x, so PCRX is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading GSK or PCRX? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysExplore the market
Free, live market tools. No account required to look.